News from Congress
Series of Bills Introduced to Improve Hospital Competition and Health Care Value -Office of Representative Victoria Spartz (R-IN-5)
In June, Rep. Spartz introduced a series of bills aimed at improving hospital competition and enhancing health care value. Highlights include:
House Republican Healthy Futures Task Force releases policy agenda -Healthy Futures Task Force House Affordability Subcommittee
In July, House Republicans released their policy proposals to promote a “modernized and personalized approach to health” and lower the cost of health coverage and health care. Notable proposals include: promoting transparency of health care prices; building on current site-neutrality provisions to ensure fair payment rates through Medicare; and conducting Congressional oversight of the Federal Trade Commission (FTC) to ensure it is properly investigating harmful health care consolidation.
The Latest from the Biden Administration
CMS Innovation Center Strategy Refresh -Center for Medicare and Medicaid Innovation (CMMI)
On November 7, the Center for Medicare and Medicaid Innovation (CMMI) published its strategy refresh to drive the health delivery system towards transformation, including focusing on equity in all initiatives; paying for health care based on value; and delivering person-centered care. The five strategic objectives include: 1) drive accountable care, 2) advance health equity, 3) support care innovations, 4) improve access by addressing affordability, and 5) partner to achieve system transformation. The goal of the strategic refresh is to ensure that the health system achieves equitable outcomes through high quality, affordable, person-centered care.
Policy Approaches to Reduce What Commercial Insurers Pay for Hospitals’ and Physicians’ Services -Congressional Budget Office (CBO)
The Congressional Budget Office released a report in September 2022, analyzing policies for lowering health care services costs in commercial insurance plans, and projecting savings for each policy option including: hospital price transparency; increased competition in health care markets; and caps on commercial health care prices-with the largest savings attributed to capping commercial health care prices.
Biden-Harris Administration Makes More Medicare Nursing Home Ownership Data Publicly Available, Improving Identification of Multiple Facilities Under Common Ownership -Centers for Medicare and Medicaid Services (CMS)
CMS published information about ownership of all Medicare-certified nursing homes as part of their continued effort to improve quality of care and facilitate transparency across facilities. The release of this data advances the President’s Executive Order to promote competition in the health care market, and comes only months after CMS, in April, publicly released data on mergers, acquisitions, consolidations, and changes of ownership of hospitals and nursing homes enrolled in Medicare from years 2016-2022. The release of this data also marks a continued effort to improve the quality of care in nursing homes, facilitating transparency and quality trends across facilities.
Inpatient Prospective Payment System (IPPS) final rule -CMS
On August 1, 2022, CMS issued the final rule for the Medicare Hospital Inpatient Prospective Payment System (IPPS) for CY23. The IPPS rule updates Medicare fee-for-service payment rates and policies for inpatient hospitals and long-term care hospitals. In the final CY23 rule, CMS adopted ten new measures for the Hospital Inpatient Quality Reporting (IQR) Program, including three health equity-focused measures; finalized a payment increase for hospitals by 4.3% (higher than the proposed rate of 3.2%); and finalized a "birthing-friendly" hospital designation to promote the quality and safety of maternity care. The rule also enacted a harmful pause in the calculation and publication of CMS Patient Safety and Adverse Events Composite (CMS PSI 90) data for FY23. This data is critical to patient and safety transparency, as it reports preventable complications from surgery attributed to hospitals.
Medicare Physician Fee Schedule (MPFS) final rule -CMS
On November 1, 2022, CMS issued the final rule for the Medicare Physician Fee Schedule (MPFS) for CY2023. The MPFS rule updates reimbursement rates for physician services. This year's rule finalizes proposals to the Medicare Shared Savings Program (MSSP) including advanced incentive payments, health equity assessments, and benchmark updates. The advanced incentive payments will encourage and support new, low revenue Accountable Care Organizations (ACOs) to participate in the program. The updated benchmarks should aid in long-term ACO participation, while the health equity assessments will adjust the ACO Merit-based Incentive Payment System (MIPS) quality reporting category score to acknowledge those ACOs that are high performing while serving a high proportion of underserved beneficiaries. The rule goes into effect January 1, 2023.
Outpatient Prospective Payment System (OPPS) final rule -CMS
On November 1, 2022 CMS issued the final rule for the Outpatient Prospective Payment System (OPPS) for CY23. The OPPS rule updates payment rates that Medicare pays to hospitals for outpatient services. The rule finalizes public health emergency (PHE) flexibility to administer behavioral health services via telehealth and allow reimbursement for remote behavioral health services provided to beneficiaries in their homes, subject to certain requirements. The rule goes into effect on January 1, 2023
Price Increases for Prescription Drugs 2016-2022 -Office for the Assistant Secretary for Planning and Evaluation (ASPE), Department of Health and Human Services (HHS)
ASPE issued a report in September 2022 that analyzed drug price changes from 2016-2022. The report adds additional evidence that drug prices are increasing faster than the rate of inflation. Between July 2021 and July 2022, there were 1,216 drugs whose price increases exceeded the inflation rate of 8.5%. The average price increase for these drugs was 31.6% with some drug prices increasing by more than 500%. In an attempt to reduce these rising drug prices, the recently passed Inflation Reduction Act will now require manufacturers to pay rebates to Medicare for Part D drugs whose price increases exceed inflation, with measurement starting October 1, 2022 in an attempt to reduce rising drug prices.
CMMI Extends BPCI Advanced Model -CMMI
The Bundled Payment for Care Improvement Advanced (BPCI Advanced) Model has been extended for another two years. The Model aims to support health care providers who invest in practice innovation and care redesign to better coordinate care and reduce expenditures, while improving the quality of care for Medicare beneficiaries.
Enhancing Oncology Model, Applications are Open -CMMI
The Enhancing Oncology Model (EOM) is a voluntary, 5 year, episodic-based payment initiative that builds on lessons from the Oncology Care Model (OCM) before it. Under this model, participating oncology practices agree to take on financial and performance accountability and improve care coordination.